Your browser doesn't support javascript.
loading
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.
Corvillo, F; Bravo García-Morato, M; Nozal, P; Garrido, S; Tortajada, A; Rodríguez de Córdoba, S; López-Trascasa, M.
Affiliation
  • Corvillo F; Unidad de Inmunología, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
  • Bravo García-Morato M; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER U754), Madrid, Spain.
  • Nozal P; Unidad de Inmunología, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
  • Garrido S; Unidad de Inmunología, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
  • Tortajada A; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER U754), Madrid, Spain.
  • Rodríguez de Córdoba S; Unidad de Inmunología, IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
  • López-Trascasa M; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER U754), Madrid, Spain.
Clin Exp Immunol ; 184(1): 118-25, 2016 Apr.
Article in En | MEDLINE | ID: mdl-26660535

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteinuria / Properdin / Complement Pathway, Alternative / Complement C3-C5 Convertases / Glomerulonephritis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Exp Immunol Year: 2016 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteinuria / Properdin / Complement Pathway, Alternative / Complement C3-C5 Convertases / Glomerulonephritis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Exp Immunol Year: 2016 Type: Article Affiliation country: Spain